Cargando…

Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells

Psoriasis is an inflammatory cutaneous disease mediated by T-cell dependent immune responses; however, B cells are also considered to play an important role its development. Regulatory B cells (Bregs) regulate immune responses negatively through interleukin-10 (IL-10) production. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizumaki, Kie, Horii, Motoki, Kano, Miyu, Komuro, Akito, Matsushita, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822829/ https://www.ncbi.nlm.nih.gov/pubmed/33483537 http://dx.doi.org/10.1038/s41598-021-81588-8

Ejemplares similares

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
por: Matsushita, Takashi, et al.
Publicado: (2018)

Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation
por: Wang, Yibing, et al.
Publicado: (2019)

IL-23 Induces Atopic Dermatitis-Like Inflammation Instead of Psoriasis-Like Inflammation in CCR2-Deficient Mice
por: Bromley, Shannon K., et al.
Publicado: (2013)

L-Theanine Alleviates IMQ-Induced Psoriasis Like Skin Inflammation by Downregulating the Production of IL-23 and Chemokines
por: Xu, Yaohan, et al.
Publicado: (2021)

The role of IL-23 in the immunopathogenesis of psoriasis
por: Meglio, Paola Di, et al.
Publicado: (2010)

IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitis
por: Goldstein, Jérémie D, et al.
Publicado: (2020)

Targeting IL-23 in psoriasis: current perspectives
por: Fotiadou, Christina, et al.
Publicado: (2018)

Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis
por: QIN, SI, et al.
Publicado: (2014)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

TARGETING IL-23: INSIGHTS INTO THE PATHOGENESIS AND THE TREATMENT OF PSORIASIS
por: Lima, Hermenio Cavalcante, et al.
Publicado: (2010)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
por: Haugh, Isabel M, et al.
Publicado: (2018)

Evaluation of interleukin-23 receptor (IL-23R) gene polymorphisms and serum IL-23 levels in patients with psoriasis
por: FİLİZ, Başak, et al.
Publicado: (2019)

Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
por: Saito-Sasaki, Natsuko, et al.
Publicado: (2018)

SHP2 allosteric inhibitor TK-453 alleviates psoriasis-like skin inflammation in mice via inhibition of IL-23/Th17 axis
por: Wang, Meijing, et al.
Publicado: (2022)

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors
por: Huang, Yu-Huei, et al.
Publicado: (2023)

TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production
por: Nakao, Momoko, et al.
Publicado: (2020)

An Analysis of IL-10, IL-17A, IL-17RA, IL-23A and IL-23R Expression and Their Correlation with Clinical Course in Patients with Psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2021)

Evaluating guselkumab: an anti-IL-23 antibody for the treatment of plaque psoriasis
por: Yang, Eric J, et al.
Publicado: (2019)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

A non-clinical comparative study of IL-23 antibodies in psoriasis
por: Zhou, Li, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase 2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation
por: Fujii, Kento, et al.
Publicado: (2020)

Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis
por: Wada, Yumiko, et al.
Publicado: (2012)

Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice
por: Sun, Jun, et al.
Publicado: (2013)

Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
por: Takatori, Hiroaki, et al.
Publicado: (2018)

Role of subnetworks mediated by [Formula: see text] , IL-23/IL-17 and IL-15 in a network involved in the pathogenesis of psoriasis
por: Pandey, Rakesh, et al.
Publicado: (2021)

Shifting the focus – the primary role of IL‐23 in psoriasis and other inflammatory disorders
por: Gooderham, M.J., et al.
Publicado: (2018)

Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice
por: Chen, Lili, et al.
Publicado: (2020)

Comment on: Drug Survival of IL‑12/23, IL‑17 and IL‑23 Inhibitors for Psoriasis Treatment: A Retrospective Multi‑Country, Multicentric Cohort Study
por: Borg, Emma, et al.
Publicado: (2021)

The Dichotomous Pattern of IL-12R and IL-23R Expression Elucidates the Role of IL-12 and IL-23 in Inflammation
por: Chognard, Gaëlle, et al.
Publicado: (2014)

Aminooxy acetic acid suppresses Th17-mediated psoriasis-like skin inflammation by inhibiting serine metabolism
por: Lee, Jong Yeong, et al.
Publicado: (2023)

Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases
por: Vincken, Nanette L. A., et al.
Publicado: (2022)

Dihydroartemisinin Alleviates Imiquimod-Induced Psoriasis-like Skin Lesion in Mice Involving Modulation of IL-23/Th17 Axis
por: Liu, Jiang-Min, et al.
Publicado: (2021)

Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation
por: Suárez-Fariñas, Mayte, et al.
Publicado: (2013)

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis
por: Campa, Molly, et al.
Publicado: (2015)

IL-23, but not IL-12, plays a critical role in inflammation-mediated bone disorders
por: Xu, Jiajia, et al.
Publicado: (2020)

Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways
por: Nair, Rajan P., et al.
Publicado: (2009)

Ustekinumab in Psoriasis Immunopathology with Emphasis on the Th17-IL23 Axis: A Primer
por: Quatresooz, Pascale, et al.
Publicado: (2012)

Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis
por: Miyagawa, Hanae, et al.
Publicado: (2021)

The Roles of IL-17, IL-21, and IL-23 in the Helicobacter pylori Infection and Gastrointestinal Inflammation: A Review
por: Dewayani, Astri, et al.
Publicado: (2021)

Opposing roles of endothelial and leukocyte-expressed IL-7Rα in the regulation of psoriasis-like skin inflammation
por: Vranova, Martina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ht7dnu2c8j9sk5vpe4gc58jsq0